TY - JOUR
T1 - Comparison of Different Organometallics Towards Electrophilic Aromatic 211At-Astatinations of Highly Reactive Tetrazines
AU - Poulie, Christian B M
AU - Muller, Marius
AU - Bom Pedersen, Nadia
AU - Martin, Marcel
AU - Mühlbauer, Valerie
AU - Mattiussi, Simona
AU - Jensen, Holger
AU - Herth, Matthias
AU - Battisti, Umberto Maria
N1 - © 2024 Wiley‐VCH GmbH.
PY - 2024/12/2
Y1 - 2024/12/2
N2 - Organometallics can be used as precursors for electrophilic 211At-statinations. In this report, we compared the potential of aryl trimethylsilanes, -germanes, or -stannanes to be used as precursors to 211At-label highly reactive tetrazines. Tetrazines can be used for pretargeted radioligand therapies or be applied as synthons to radiolabel rapidly and orthogonally a broad set of precursors such as peptides, mAbs or nanomedicines. All precursors could successfully be synthesized and radiolabeled. The reactivity of organogermanium reagents ranged between those of respective organotin and organosilicon precursors. Moreover, organogermanium reagents proved promising for accessing more complex and polar tetrazine scaffolds. In contrast to organotin derivatives, the use of protecting groups could be avoided for organogermanium and -silicon precursors. The developed 211At-labeled tetrazines could be labeled in radiochemical conversions of 60-90%. Organogermanium and -silicon precursors were clearly advantaged as additional deprotection steps could avoided. Reported labeling procedures allow astatinations of highly reactive tetrazines to be used for pretargeted approaches or to applied as highly reactive synthons to label the next-generation of 211At-labeled radiopharmaceuticals.
AB - Organometallics can be used as precursors for electrophilic 211At-statinations. In this report, we compared the potential of aryl trimethylsilanes, -germanes, or -stannanes to be used as precursors to 211At-label highly reactive tetrazines. Tetrazines can be used for pretargeted radioligand therapies or be applied as synthons to radiolabel rapidly and orthogonally a broad set of precursors such as peptides, mAbs or nanomedicines. All precursors could successfully be synthesized and radiolabeled. The reactivity of organogermanium reagents ranged between those of respective organotin and organosilicon precursors. Moreover, organogermanium reagents proved promising for accessing more complex and polar tetrazine scaffolds. In contrast to organotin derivatives, the use of protecting groups could be avoided for organogermanium and -silicon precursors. The developed 211At-labeled tetrazines could be labeled in radiochemical conversions of 60-90%. Organogermanium and -silicon precursors were clearly advantaged as additional deprotection steps could avoided. Reported labeling procedures allow astatinations of highly reactive tetrazines to be used for pretargeted approaches or to applied as highly reactive synthons to label the next-generation of 211At-labeled radiopharmaceuticals.
KW - Germanium/chemistry
KW - Isotope Labeling
KW - Organometallic Compounds/chemistry
KW - Organotin Compounds/chemistry
KW - Radiopharmaceuticals/chemistry
KW - Tetrazoles/chemistry
KW - Alpha-emitters
KW - Targeted alpha therapy
KW - Tetrazine ligation
KW - Astatine-211
UR - http://www.scopus.com/inward/record.url?scp=85208625541&partnerID=8YFLogxK
U2 - 10.1002/chem.202403446
DO - 10.1002/chem.202403446
M3 - Journal article
C2 - 39412494
SN - 0947-6539
VL - 30
JO - Chemistry - A European Journal
JF - Chemistry - A European Journal
IS - 67
M1 - e202403446
ER -